GHK-Cu vs Thymosin Beta-4 (Tβ4)
Updated November 4, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of GHK-Cu and Thymosin Beta-4 (Tβ4) (also searched as Thymosin Beta-4 (Tβ4) vs GHK-Cu) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
GHK-Cu centers on skin, while Thymosin Beta-4 (Tβ4) leans toward healing. On indexed research, GHK-Cu is ahead (GHK-Cu: 27 studies, Preclinical; Thymosin Beta-4 (Tβ4): 6, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •GHK-Cu is strongest for skin; Thymosin Beta-4 (Tβ4) for healing.
- •Evidence: GHK-Cu Preclinical (27 studies) vs Thymosin Beta-4 (Tβ4) Human clinical (6).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
Copper-binding | Skin and wound healing
Tissue repair | Wound healing
GHK-Cu vs Thymosin Beta-4 (Tβ4): side-by-side
| Metric | GHK-Cu | Thymosin Beta-4 (Tβ4) |
|---|---|---|
| Class | Healing | Healing |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Preclinical | Human clinical |
| Studies indexed | 27 | 6 |
| Research level | Preclinical | Moderate Research |
| Strongest effect | Skin & aesthetics | Healing & recovery |
| Healing & recovery | 5.0▲ | 5.0▲ |
| Muscle & body comp | 1.0 | 2.0▲ |
| Metabolic & appetite | 2.0▲ | 1.0 |
| Neuro & mood | 1.0 | 3.0▲ |
| Sleep & circadian | 0.0 | 1.0▲ |
| Inflammation & immune | 4.0▲ | 4.0▲ |
| Skin & aesthetics | 5.0▲ | 2.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | GHK-Cu | Thymosin Beta-4 (Tβ4) |
|---|---|---|
| Mechanism | Copper-binding tripeptide (GHK-Cu); tissue-remodeling / regenerative signaling | Actin-sequestering peptide; promotes cell migration & angiogenesis |
| Route | Topical / subcutaneous | Subcutaneous injection (research use) |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is GHK-Cu?
Copper-binding tripeptide widely used in skin, hair, and wound-healing contexts, with systemic effects explored in research.
Full GHK-Cu profile, mechanism & studies →What is Thymosin Beta-4 (Tβ4)?
Thymosin Beta-4 (Tβ4) is a 43-amino acid peptide that plays a significant role in tissue repair and regeneration. It is involved in various biological processes, including cell migration, angiogenesis, and inflammation modulation. Tβ4 has been shown to promote wound healing by enhancing keratinocyte migration and proliferation, as well as by facilitating the formation of new blood vessels, which are crucial for tissue repair.
Full Thymosin Beta-4 (Tβ4) profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~5.0/5 |
| Muscle | Thymosin Beta-4 (Tβ4) | 2.0/5 effect signal |
| Metabolic | GHK-Cu | 2.0/5 effect signal |
| Neuro | Thymosin Beta-4 (Tβ4) | 3.0/5 effect signal |
| Sleep | Thymosin Beta-4 (Tβ4) | 1.0/5 effect signal |
| Inflammation | Even | Both ~4.0/5 |
| Skin | GHK-Cu | 5.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack GHK-Cu and Thymosin Beta-4 (Tβ4)?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
GHK-Cu vs Thymosin Beta-4 (Tβ4): side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
GHK-Cu has 27 approved studies indexed (Preclinical), and Thymosin Beta-4 (Tβ4) has 6 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is GHK-Cu or Thymosin Beta-4 (Tβ4) better?
It depends on your goal. GHK-Cu is strongest for skin; Thymosin Beta-4 (Tβ4) for healing. GHK-Cu has more indexed studies (27). See the goal-by-goal breakdown above.
Is GHK-Cu or Thymosin Beta-4 (Tβ4) better for weight loss?
GHK-Cu shows the stronger metabolic & appetite profile (2.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is GHK-Cu or Thymosin Beta-4 (Tβ4) better for muscle?
Thymosin Beta-4 (Tβ4) leads on the muscle & body-composition axis (2.0/5).
Which has more research, GHK-Cu or Thymosin Beta-4 (Tβ4)?
GHK-Cu has 27 approved studies indexed (Preclinical); Thymosin Beta-4 (Tβ4) has 6 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack GHK-Cu and Thymosin Beta-4 (Tβ4)?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of GHK-Cu vs Thymosin Beta-4 (Tβ4)?
GHK-Cu: no community-reported effects logged yet. Thymosin Beta-4 (Tβ4): none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is GHK-Cu or Thymosin Beta-4 (Tβ4) FDA-approved?
GHK-Cu is a research-use compound and is not FDA-approved. Thymosin Beta-4 (Tβ4) is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Thymosin Beta-4 (Tβ4) better than GHK-Cu?
For healing, Thymosin Beta-4 (Tβ4) has the edge; for skin, GHK-Cu does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
GHK-Cu and Thymosin Beta-4 (Tβ4) are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed November 4, 2026.